Comparison · NCT05736861-722f18ed
Arm A - Ivermectin 400 vs Arm A - Placebo: Number of Participants With Hospitalization or Death
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. Arm A - Ivermectin 400 vs Arm A - Placebo: Number of Participants With Hospitalization or Death. Trial comparisons, record NCT05736861-722f18ed. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT05736861-722f18ed
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.0122 | 0.00666 | 0.0224 | wilson | |
| Risk in group 2 | 0.0116 | 0.00613 | 0.022 | wilson | |
| Risk difference, group 1 minus group 2 | 0.000612 | -0.0111 | 0.0121 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 1.05 | 0.43 | 2.58 | log | |
| Odds ratio, group 1 over group 2 | 1.05 | 0.426 | 2.61 | log | |
| Number needed to treat, for one more participant with the outcome on Arm A - Ivermectin 400 than on Arm A - Placebo | 1,630 | from the risk difference interval | the interval includes no difference |
Source ClinicalTrials.gov
Groups2
Group 2 names the comparator: placebo.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | Arm A - Ivermectin 400 | Ivermectin - 7-mg tablets~Participant will be instructed to take a pre-specified number of tablets for 3 consecutive days based on their weight for a daily dose of approximately 300-400 µg/kg.~Ivermectin: Each participant will receive a sufficient quantity of 7-mg tablets to be taken as directed based on their weight. The tablets are white, round, biconvex tablets with 123 over the scoring on one side. All packaging will be labeled to indicate that the product is for investigational use. | 10 | 817 | OG000 |
| Group 2 | Arm A - Placebo | Placebo - appearance and size matched to active study drug.~Participant will be instructed to take a pre-specified number of tablets for 3 consecutive days based on their weight, matched to active study drug dosing.~Placebo: Each study arm will contain a placebo comparator. Placebo will look similar to study drug and will be administered via the same route of administration and dose. However, placebo will be an inactive substance, containing no study drug. | 9 | 774 | OG001 |
Source ClinicalTrials.gov
Outcome
- Type
- SECONDARY
- Title
- Number of Participants With Hospitalization or Death
- Description
- Time frame
- Up to 28 days
- Population
Source ClinicalTrials.gov
Trial
- Title
- ACTIV-6: COVID-19 Study of Repurposed Medications - Arm A (Ivermectin 400)
- NCT number
- NCT05736861
- Phases
- PHASE3
- Conditions
- Covid19
- Interventions
- Ivermectin, Placebo
- Lead sponsor
- Susanna Naggie, MD
- Results first posted
- 2023-04-11
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT05736861?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT05736861-722f18ed